Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M76,373Revenue $M17,005Net Margin (%)17.8Z-Score4.3
Enterprise Value $M75,587EPS $3.0Operating Margin %21.6F-Score5
P/E(ttm))26.8Cash Flow Per Share $4.4Pre-tax Margin (%)21.6Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %7.1Quick Ratio2.8Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %8.1Current Ratio3.1Lower Leverage y-yY
Price/Cash Flow9.7y-y EBITDA Growth Rate %-16.5ROA % (ttm)7.6Higher Current Ratio y-yN
Dividend Yield %1.5Insider Buy (3m)0ROE % (ttm)16.0Less Shares Outstanding y-yY
Payout Ratio %40.0Shares Outstanding M984ROI % (ttm)3.1Gross Margin Increase y-yN

Gurus Latest Trades with MDT

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MDTJohn Hussman 2014-12-31 Buy 1.4%$61.81 - $75.57
($69.56)
$ 77.5912%New holding, 200000 sh.200,000
MDTVanguard Health Care Fund 2014-12-31 Add0.11%$61.81 - $75.57
($69.56)
$ 77.5912%Add 5.2%13,047,000
MDTRay Dalio 2014-12-31 Add0.01%$61.81 - $75.57
($69.56)
$ 77.5912%Add 35.45%36,632
MDTRuane Cunniff 2014-12-31 Reduce$61.81 - $75.57
($69.67)
$ 77.5911%Reduce -51.55%4,700
MDTPRIMECAP Management 2014-12-31 Reduce-0.74%$61.81 - $75.57
($69.56)
$ 77.5912%Reduce -37.1%18,578,166
MDTAndreas Halvorsen 2014-12-31 Sold Out -0.46%$61.81 - $75.57
($69.67)
$ 77.5911%Sold Out0
MDTJoel Greenblatt 2014-12-31 Reduce-0.3%$61.81 - $75.57
($69.67)
$ 77.5911%Reduce -96.05%19,608
MDTJean-Marie Eveillard 2014-12-31 Reduce-0.09%$61.81 - $75.57
($69.56)
$ 77.5912%Reduce -30.95%1,236,314
MDTMario Gabelli 2014-12-31 Reduce-0.01%$61.81 - $75.57
($69.56)
$ 77.5912%Reduce -75%10,000
MDTAndreas Halvorsen 2014-09-30 Buy 0.46%$61 - $66.53
($63.6)
$ 77.5922%New holding, 1841414 sh.1,841,414
MDTJoel Greenblatt 2014-09-30 Add0.3%$61 - $66.53
($63.6)
$ 77.5922%Add 5179.96%496,211
MDTHOTCHKIS & WILEY 2014-09-30 Add0.29%$61 - $66.53
($63.6)
$ 77.5922%Add 67.19%3,230,958
MDTRobert Olstein 2014-09-30 Add0.21%$61 - $66.53
($63.6)
$ 77.5922%Add 23.48%142,000
MDTRay Dalio 2014-09-30 Buy 0.01%$61 - $66.53
($63.6)
$ 77.5922%New holding, 27045 sh.27,045
MDTRuane Cunniff 2014-09-30 Buy $61 - $66.53
($63.6)
$ 77.5922%New holding, 9700 sh.9,700
MDTScott Black 2014-09-30 Sold Out -0.4%$61 - $66.53
($63.6)
$ 77.5922%Sold Out0
MDTRobert Olstein 2014-06-30 Buy 0.99%$58.05 - $64.67
($60.7)
$ 77.5928%New holding, 115000 sh.115,000
MDTJean-Marie Eveillard 2014-06-30 Buy 0.32%$58.05 - $64.67
($60.7)
$ 77.5928%New holding, 2098343 sh.2,098,343
MDTVanguard Health Care Fund 2014-06-30 Add0.18%$58.05 - $64.67
($60.7)
$ 77.5928%Add 9.39%12,402,000
MDTMario Gabelli 2014-06-30 Buy 0.01%$58.05 - $64.67
($60.7)
$ 77.5928%New holding, 40000 sh.40,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MDT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MDT John Hussman 2014-12-31200,0000.021.4New Buy
MDT Ray Dalio 2014-12-3136,63200.02+35.45%
MDT Vanguard Health Care Fund 2014-12-3113,047,0001.332.2+5.2%
MDT James Barrow 2014-12-3132,638,4543.323.2+0.49%
MDT Ken Fisher 2014-12-316,19300+0.45%
MDT Bill Nygren 2014-12-314,690,0000.482
MDT Dodge & Cox 2014-12-318,817,7730.90.59-0.53%
MDT HOTCHKIS & WILEY 2014-12-313,207,8840.330.81-0.71%
MDT John Keeley 2014-12-3133,18000.05-0.84%
MDT Robert Olstein 2014-12-31134,0000.011.2-5.63%
MDT Jean-Marie Eveillard 2014-12-311,236,3140.130.22-30.95%
MDT PRIMECAP Management 2014-12-3118,578,1661.891.4-37.1%
MDT Ruane Cunniff 2014-12-314,70000-51.55%
MDT Mario Gabelli 2014-12-3110,00000-75%
MDT Joel Greenblatt 2014-12-3119,60800.01-96.05%
MDT Andreas Halvorsen 2014-12-31000Sold Out
MDT Bill Nygren 2014-09-304,690,0000.481.9+1.85%
Premium Most recent portfolio changes are included for Premium Members only!


MDT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OConnell Christopher JEVP & GroupPres Restora Therap 2015-02-19Sell50,361$78.220.46view
Kuntz RichardSrVP & Chief Scien, Clin, Reg 2014-12-19Sell12,855$74.545.42view
JACKSON SHIRLEY ADirector 2014-12-02Sell1,102$74.435.58view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-11-28Sell42,921$73.956.26view
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc 2014-10-09Sell370$64.0722.65view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-10-06Sell15,388$64.9820.93view
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc 2014-10-03Sell571$65.0320.84view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-08-26Sell28,000$63.5723.61view
JACKSON SHIRLEY ADirector 2014-08-26Sell2,769$63.6623.44view
Szyman Catherine MSrVP & Pres Diabetes 2014-04-17Sell29,420$58.7933.66view

Press Releases about MDT :

    Quarterly/Annual Reports about MDT:

    News about MDT:

    Articles On GuruFocus.com
    Medtronic (MDT) Momentum at All-Time-High Levels, Knowles (KN) Rating Boosted Feb 21 2015 
    Medtronic Q3 Earnings 2015 Exceeds Market Expectations Feb 19 2015 
    A Robust Q4 Earnings Report From Boston Scientific Feb 10 2015 
    A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
    Steven Romick Shorts Alibaba, Medtronic in Q4 Jan 20 2015 
    Toro: A Quality Company with Strong Prospects Dec 19 2014 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    Boston Scientific Lost the First Place in Innovation Dec 11 2014 
    Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 
    Dividend Aristocrats In Focus Part 44: Medtronic Nov 23 2014 


    More From Other Websites
    Medtronic Adds Advanced Uro-Solutions to Neuromodulation - Analyst Blog Feb 24 2015
    Street Talk: CSC, STJ, AEO, RIG & PETX Feb 24 2015
    FDA Approves the VenaSeal(TM) Closure System for Treatment of Clinically Symptomatic Venous Reflux Feb 24 2015
    1:01 pm Medtronic announces FDA approval for VenaSeal closure system Feb 24 2015
    Medtronic's Artificial Pancreas Technology: Key to Diabetes Cure? - Analyst Blog Feb 23 2015
    Medtronic buys maker of device for overactive bladders Feb 23 2015
    Medtronic Acquires Advanced Uro-Solutions Feb 23 2015
    Medtronic Acquires Advanced Uro-Solutions Feb 23 2015
    Friday's Market Recap Feb 20 2015
    Medtronic's device for varicose veins wins FDA approval Feb 20 2015
    Ireland's Leading Stocks: Looking Past The Inversions Feb 19 2015
    Study Shows Medtronic Deep Brain Stimulation Therapy for Treatment-Resistant Epilepsy Demonstrates... Feb 19 2015
    Medtronic And Boston Scientific Plan To Resume Blood Pressure Trials This Year Feb 19 2015
    Medicare Approves Transitional Pass-Through Payment for Outpatient Use of Medtronic Drug-Coated... Feb 19 2015
    Medtronic Hits 52-Week High on Solid Q3, Portfolio Strength - Analyst Blog Feb 18 2015
    Stock Market News for February 18, 2015 - Market News Feb 18 2015
    Trader sees Medtronic holding gains Feb 18 2015
    Wedbush Securities Believes Positive FY3Q15 Results Bode Well For Medtronic Feb 18 2015
    Medtronic Leads Progress Toward an Artificial Pancreas for People with Diabetes Feb 18 2015
    Medtronic's Spinal System Wins FDA Nod for Expanded Use - Analyst Blog Feb 17 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK